Dear Sir/Madam,
Welcome and thank you for taking the time to visit our website.
I am pleased to have the opportunity to address you for the first time since China Pioneer Pharma Holdings Limited became the majority shareholder of Covex S.A. on 1 July 2014, having made a significant investment in order to strengthen the financial equity of Covex S.A. and thus ensure that Covex’s ambitious plans for its development are realised.
We have decided to acquire a stake in Covex for many reasons, of which I consider particularly noteworthy:
European Quality
high standards in its products
40 years
extensive experience in the sector
60 countries
customers around the world
Team
highly specialised
I am confident that these values will be reinforced by the fact that Covex is now part of China Pioneer Pharma Holdings Limited, a group listed on the Hong Kong Stock Exchange (Stock Code 01345), and is committed to providing its customers with the best service as they grow their business.
I hope you will join us in this new venture and share in the success we are sure to achieve together.
Yours sincerely,
Ms. Wei Juan Lai (Fiona)
CEO
